Three-dimensional quantitative muscle ultrasound in patients with facioscapulohumeral dystrophy and myotonic dystrophy

被引:4
|
作者
de Jong, Leon [1 ]
Greco, Anna [2 ]
Nikolaev, Anton [1 ]
Weijers, Gert [1 ]
van Engelen, Baziel G. M. [2 ]
de Korte, Chris L. L. [1 ]
Futterer, Jurgen J. J. [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Dept Med Imaging, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands
基金
欧盟地平线“2020”;
关键词
diagnostic criteria; FSHD; muscle ultrasound; myotonic dystrophy; quantitative ultrasound; three-dimensional ultrasound;
D O I
10.1002/mus.27943
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction/AimsUltrasound imaging of muscle tissue conventionally results in two-dimensional sampling of tissue. For heterogeneously affected muscles, a sampling error using two-dimensional (2D) ultrasound can therefore be expected. In this study, we aimed to quantify and extend ultrasound imaging findings in neuromuscular disorders by using three-dimensional quantitative muscle ultrasound (3D QMUS). MethodsPatients with facioscapulohumeral dystrophy (n = 31) and myotonic dystrophy type 1 (n = 16) were included in this study. After physical examination, including Medical Research Council (MRC) scores, the tibialis anterior muscle was scanned with automated ultrasound. QMUS parameters were calculated over 15 cm of the length of the tibialis anterior muscle and were compared with a healthy reference data set. ResultsWith 3D QMUS local deviations from the healthy reference could be detected. Significant Pearson correlations (P < .01) between MRC score and QMUS parameters in male patients (n = 23) included the mean echo intensity (EI) (0.684), the standard deviation of EI (0.737), and the residual attenuation (0.841). In 91% of all patients, mean EI deviated by more than 1 standard deviation from the healthy reference. In general, the proportion of muscle tissue with a Z score >1 was about 50%. DiscussionIn addition to mean EI, multiple QMUS parameters reported in this study are potential biomarkers for pathology. Besides a moderate correlation of mean EI with muscle weakness, two other parameters showed strong correlations: standard deviation of EI and residual attenuation. Local detection of abnormalities makes 3D QMUS a promising method that can be used in research and potentially for clinical evaluation.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 50 条
  • [31] Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy
    Kan, Hermien E.
    Scheenen, Tom W. J.
    Wohlgemuth, Marielle
    Klomp, Dennis W. J.
    van Loosbroek-Wagenmans, Ivonne
    Padberg, George W.
    Heerschap, Arend
    NEUROMUSCULAR DISORDERS, 2009, 19 (05) : 357 - 362
  • [32] Muscle phenotype in patients with myotonic dystrophy type 1
    Andersen, Grete
    Orngreen, Mette C.
    Preisler, Nicolai
    Colding-Jorgensen, Eskild
    Clausen, Torben
    Duno, Morten
    Jeppesen, Tina D.
    Vissing, John
    MUSCLE & NERVE, 2013, 47 (03) : 409 - 415
  • [33] Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue
    Kalkman, Joke S.
    Zwarts, Machiel J.
    Schillings, Maartje L.
    van Engelen, Baziel G. M.
    Bleijenberg, Gijs
    NEUROLOGICAL SCIENCES, 2008, 29 (Suppl 2) : S238 - S240
  • [34] Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue
    Joke S. Kalkman
    Machiel J. Zwarts
    Maartje L. Schillings
    Baziel G. M. van Engelen
    Gijs Bleijenberg
    Neurological Sciences, 2008, 29 : 238 - 240
  • [35] Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients
    Konstantonis, Dimitrios
    Kekou, Kyriaki
    Papaefthymiou, Petros
    Vastardis, Heleni
    Konstantoni, Nikoleta
    Athanasiou, Maria
    Svingou, Maria
    Margariti, Anastasia
    Panousopoulou, Angeliki
    CHILDREN-BASEL, 2022, 9 (01):
  • [36] Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1
    Lareau-Trudel, Emilie
    Le Troter, Arnaud
    Ghattas, Badih
    Pouget, Jean
    Attarian, Shahram
    Bendahan, David
    Salort-Campana, Emmanuelle
    PLOS ONE, 2015, 10 (07):
  • [37] Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I
    Kalkman, J. S.
    Schillings, M. L.
    Zwarts, M. J.
    van Engelen, B. G. M.
    Bleijenberg, G.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (04): : 265 - 270
  • [38] Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy
    Furling, D
    Lam, LT
    Agbulut, O
    Butler-Browne, GS
    Morris, GE
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (03): : 1001 - 1009
  • [39] Quantitative motor assessment in myotonic dystrophy
    Mathieu, J
    Boivin, H
    Richards, CL
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2003, 30 (02) : 129 - 136
  • [40] QUANTITATIVE EMG MYOTONIC-DYSTROPHY
    CANEDO, J
    MASSEY, JM
    NANDEDKAR, S
    SANDERS, DB
    MUSCLE & NERVE, 1989, 12 (09) : 761 - 761